Morgan Stanley Maintains Overweight on Sempra, Lowers Price Target to $100
Morgan Stanley analyst David Arcaro maintains Sempra (NYSE:SRE) with a Overweight and lowers the price target from $104 to $100.
Stocks · News reference
JP Morgan Maintains Overweight on Sempra, Lowers Price Target to $102
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading